agilon health, inc. (NYSE:AGL) Stock Holdings Increased by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC raised its position in shares of agilon health, inc. (NYSE:AGL) by 65.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 804,594 shares of the company’s stock after buying an additional 316,856 shares during the quarter. Susquehanna Fundamental Investments LLC owned about 0.20% of agilon health worth $5,262,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of AGL. J.Safra Asset Management Corp boosted its holdings in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the period. Neo Ivy Capital Management acquired a new stake in shares of agilon health during the 4th quarter worth approximately $47,000. CWM LLC lifted its holdings in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new stake in shares of agilon health in the 2nd quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC acquired a new position in agilon health during the 1st quarter valued at approximately $65,000.

Insider Transactions at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 3.20% of the company’s stock.

agilon health Price Performance

Shares of NYSE AGL opened at $3.74 on Monday. agilon health, inc. has a twelve month low of $3.07 and a twelve month high of $20.37. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average of $4.83 and a two-hundred day moving average of $5.45. The company has a market capitalization of $1.54 billion, a price-to-earnings ratio of -5.34 and a beta of 0.54.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year. During the same period last year, the firm posted ($0.04) earnings per share. As a group, analysts expect that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Evercore ISI raised their target price on agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research note on Tuesday, July 9th. Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $8.57.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.